Vaccination with peptide 173-193 of acetylcholine receptor α7-subunit prevents memory loss in olfactory bulbectomized mice

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 249-261

  Kamynina, Anna V ^a   Volpina, Olga M ^a   Medvinskaya, Natalya I ^b   Aleksandrova, Irina Ju ^b   Volkova, Tatyana D ^a   Koroev, Dmitriy O ^a   Samokhin, Aleksandr N ^b   Nesterova, Inna V ^b   Shelukhina, Irina V ^a   Kryukova, Elena V ^a   Tsetlin, Viktor I ^a   Ivanov, Vadim T ^a   Bobkova, Natalya V ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

Author keywords

Alzheimer's disease; amyloid ; immunization; olfactory bulbectomized mice; peptide fragments; spatial memory; 7 subunit of the nicotinic acetylcholine receptor

Indexed keywords

ACETYLCHOLINE RECEPTOR 1; ACETYLCHOLINE RECEPTOR 7; AMYLOID BETA PROTEIN; CHOLINERGIC RECEPTOR; PEPTIDE; PEPTIDE 173-193; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CHRNA7 PROTEIN, MOUSE; IODINE; NICOTINIC RECEPTOR; PROTEIN BINDING;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN TISSUE; CEREBROSPINAL FLUID; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SPATIAL MEMORY; ACTIVE IMMUNIZATION; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COMPLICATION; DOSE RESPONSE; IMMUNOLOGY; MALE; MAZE TEST; MEMORY DISORDERS; METABOLISM; OLFACTION DISORDERS; OLFACTORY BULB; PHYSIOLOGY; PROCEDURES; SURGERY;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; BUNGAROTOXINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; IMMUNOTHERAPY, ACTIVE; IODINE ISOTOPES; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; OLFACTION DISORDERS; OLFACTORY BULB; PEPTIDES; PROTEIN BINDING; RECEPTORS, NICOTINIC;

EID: 77954969815     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091474     Document Type: Article

References (60)

1. Hardy J, Selkoe DJ (2002) Medicine-the amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
2. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's A-beta peptide induces neurode-generation and apoptotic cell death in transgenic mice. Nat Genet 9,21-30.
3. Chui DH, Dobo E, Makifuchi T, Akiyama H, Kawakatsu S, Petit A, Checler F, Araki W, Takahashi K, Tabira T (2001) Apoptotic neurons in Alzheimer's disease frequently show intracellular Abeta42 labeling. J Alzheimers Dis 3, 231-239.
4. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403.
5. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Ma-malaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK (1999) a4 but not a3 and a7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. JNeurochem 73, 1635-1640.
6. Guan ZZ, Zhang X, Ravid R, Nordberg A (2000) Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex ofpatients with Alzheimer's disease. J Neurochem 74, 237-243.
7. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E (2001) Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49, 175-184.
8. Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK (2004) Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci 225, 39-49.
9. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) Beta-Amyloid(1-42) binds to alpha7 nico-tinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. Biol Chem 275, 5626-5632.
10. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211.
11. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134.
12. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF. (2009) Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29, 88058815.
13. Espinoza-Fonsecaa L, Trujillo-Ferrara J. (2006) Fully flexible docking models of the complex between a7 nicotinic receptor and a potent heptapeptide inhibitor of the b-amyloid peptide binding. BioorgMed Chem Lett 16, 3519-3523.
14. Wang HY, Stucky A, Liu J, Shen C, Trocme-Thibierge C, Morain P (2009) Dissociating beta-amyloid from alpha 7 nico-tinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain. J Neurosci 29, 10961-10973.
15. Ganor Y, Gottlieb M, Eilam R, Otmy H, Teichberg VI, Levite M. (2005) Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. Exp Neurol 195, 92-102.
16. Leonard BE, Tuite M (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22,251-286.
17. Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model ofdepression. Neurosci Biobehav Rev 29, 627-647.
18. Yamamoto T, Jin J, Watanabe S (1997) Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav Brain Res 83, 57-62.
19. Nesterova IV, Gurevich EV, Nesterov VI, Otmakhova NA, Bobkova NV (1997) Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog Neu-ropsychopharmacol Biol Psychiatry 21, 127-140.
20. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A, Arai Y, Yasuhara H, Tadano T (2003) Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res 138, 9-15. (Pubitemid 35463233)
21. Bobkova NV, Nesterova IV, Dana R, Dana E, Nesterov VI, Aleksandrova Y, Medvinskaya NI, Samokhin AN (2004) Morphofunctional changes in neurons in the temporal cortex of the brain in relation to spatial memory in bulbectomized mice after treatment with mineral ascorbates. Neurosci Behav Physiol 34, 671-676.
22. Nesterova IV, Bobkova NV, Medvinskaya NI, Samokhin AN, Aleksandrova IY (2008) Morphofunctional state of neurons in the temporal cortex and hippocampus in relation to the level of spatial memory in rats after ablation of the olfactory bulbs. Neurosci Behav Physiol 38, 349-353.
23. Bobkova NV, Nesterova IV, Nesterov VV (2001) The state of cholinergic structures in forebrain of bulbectomized mice. Bull Exp Biol Med 131, 427-431.
24. Struble RG, Dhanraj DN, Mei Y, Wilson M, Wang R, Ramku-mar V (1998) Beta-amyloid precursor protein-like immunore-activity is upregulated during olfactory nerve regeneration in adult rats. Brain Res 780, 129-137.
25. Aleksandrova IY, Kuvichkin VV, Kashparov IA, Medvinskaya NI, Nesterova IV, Lunin SM, Samokhin AN, Bobkova NV (2004) Increased level of beta-amyloid in the brain of bulbec-tomized mice. Biochemistry (Moscow) 69, 176-180.
26. Bobkova N, Vorobyov V, Medvinskaya N, Aleksandrova I, Nesterova I (2008) Interhemispheric EEG differences in olfactory bulbectomized rats with different cognitive abilities and brain beta-amyloid levels. Brain Res 1232, 185-194.
27. Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR (1986) Olfactory deficits and Alzheimer's disease. Biol Psychiat 2, 116-118.
28. Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centers in Alzheimer's disease: olfactory bulb is involved in early Braak's stage. Neuroreport 12, 285-1228
29. Lee HB, Lyketsos CG (2003) Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry 54, 353-362.
30. Pentzek M, Grass-Kapanke B, Ihl R (2007) Odor identification in Alzheimer's disease and depression. Aging Clin Exp Res 19, 255-258.
31. Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RD, Gu-dasheva TA, Samokhin AN, Seredinin SB, Noppe W, Sher-stnev VV, Morozova-Roche LA (2007) The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model. J Psychopharmacol 21, 611619.
32. Nakajima A, Yamakuni T, Haraguchi M, Omae N, Song SY, Kato C, Nakagawasai O, Tadano T, Yokosuka A, Mimaki Y, Sashida Y, Ohizumi Y (2007) Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci 105, 122-126.
33. Han F, Shioda N, Moriguchi S, Yamamoto Y, Raie AY, Ya-maguchi Y, Hino M, Fukunaga K (2008) Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein ki-nase C in mouse hippocampus. J Pharmacol Exp Ther 326, 127-134.
34. Volpina OM, Titova MA, Koroev DO, Volkova TD, Oboznaya MB, Zhmak MN, Alekseev TA, Tsetlin VI (2006) Production of antibodies to the alpha7-subunit of human acetylcholine nicotinic receptor with the use of immunoactive synthetic peptides. RusJ Bioorg Chem 32, 154-159.
35. Tsetlin V, Shelukhina I, Krukova E, Burbaeva G, Starodubt-seva L, Skok M, Volpina O, Utkin Yu (2007) Detection of a7 nicotinic acetylcholine receptors with the aid ofantibodies and toxins. Life Sci 80, 2202-2205. (Pubitemid 46818258)
36. Volpina OM, Volkova TD, Titova MA, Gershovich IG, Med-vinskaia NI, Samokhin AN, Kamynina AV, Shalgunov VS, Koroev DO, Filatova MP, Oboznaia MB, Bobkova NV (2008) New approaches to the immunotherapy of Alzheimer's disease with the synthetic fragments of alpha7 subunit of the acetylcholine receptor. Rus J Bioorg Chem 34, 50-55.
37. Volpina OM, Titova MA, Zhmak MN, Koroev DO, Oboznaya MB, Volkova TD, Ivanov VT (2002) Structure prediction for peptides capable of inducing antibody formation in mice. Rus J Bioorg Chem 28, 349-356.
38. Sc propagation in prion-infected cells. Cell Mol Neurobiol 27, 271-284.
39. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60.
40. Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. AnalBiochem 83, 346-356.
41. Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ (2000) [125 I]-a-Conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol 57, 913-925.
42. Kukhtina VV, Weise K, Osipov AV, Starkov VG, Titov MI, Esipov SE, Ovchinnikova TV, Tsetlin VI, Utkin IN (2000) MALDI-mass spectrometry for identification of new proteins in snake venoms. Rus J Bioorg Chem 26, 721-724.
43. Tsetlin V, Utkin Y, Kasheverov I (2009) Polypeptide and pep-tide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors. Biochem Pharmacol 78, 720-731.
44. Chen D, Patrick JW (1997) The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit, J Biol Chem 272, 24024-24029.
45. Barik J, Wonnacott S. (2006) Indirect modulation by a7 nico-tinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacology 69, 618-628.
46. Mathew SV, Law AJ, Lipska BK, Davila-Garcia MI, Zamora ED, Mitkus SN, Vakkalanka R, Straub RE, Weinberger DR, Kleinman JE, Hyde TM (2007) a7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Hum Mol Genet 16, 2921-2932.
47. Moser N, Mechawar NI, Gochberg-Sarver JA, Orr-Urtreger A, Plomann M, Salas R, Molles B, Marubio L, Roth U, Maskos U, Winzer-Serhan U, Bourgeois JP, Le Sourd AM, De Biasi M, Schroder H, Lindstrom J, Maelicke A, Changeux JP, Wevers A (2007) Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 102, 479-492.
48. Fairclough RH, Twaddle GM, Gudipati E, Lin MY, Richman DP (1998) Differential surface accessibility of alpha(187-199) in the Torpedo acetylcholine receptor alpha subunits. J Mol Biol 282, 317-330.
49. Middleton RE, Cohen JB (1991) Mapping of the acetyl-choline binding site of the nicotinic acetylcholine receptor: [3H]nicotine as an agonist photoaffinity label. Biochemistry 30, 6987-6997.
50. Sine SM, Engel AG (2006) Recent advances in Cys-loop receptor structure and function. Nature 440, 448-455.
51. Sieck MH (1972) The role of the olfactory system in avoidance learning and activity. Physiol Behav 8, 705-710.
52. Leung CH, Wilson DA (2003) Trans-neuronal regulation of cortical apoptosis in the adult rat olfactory system. Brain Res 984, 182-188.
53. Koliatsos VE, Dawson TM, Kecojevic A, Zhou Y, Wang YF, Huang KX (2004) Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons. Proc Natl Acad Sci USA 101, 14264-14269.
54. Capurso SA, Calhoun ME, Sukhov RR, Mouton PR, Price DL, Koliatsos VE (1997) Deafferentation causes apoptosis in cortical sensory neurons in the adult rat. J Neurosci 17, 73727384.
55. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K (2008) The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bul-bectomized mice. Neuroscience 151, 671-679.
56. Van der Stelt HM, Breuer ME, Olivier B, Westenberg HG, Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry 57, 1061-1067.
57. Herregodts P, Bruyland M, De Keyser J, Solheid C, Michotte Y, Ebinger G (1989) Monoaminergic neurotransmitters in Alzheimers disease. An HPLC study comparing presenile familial and sporadic senile cases. J Neurol Sci 92, 101-116.
58. Moriguchi S, Han F, Nakagawasai O, Tadano T, Fukunaga KD, Decreased calcium/calmodulin-dependent protein ki-nase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbec-tomized mice. J Neurochem 97, 22-29.
59. Deane R, Zlokovic BV (2007) Role ofthe blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 4, 191-197.
60. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA (2009) Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med, in press.